ProCE Banner Activity

Express Points
Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC

Slideset Download
Download this short summary slideset summarizing clinical trial data presented at a live CCO Webinar featuring expert discussion on the increasing role of antibody-drug conjugates in advanced NSCLC.

Released: April 14, 2021

Expiration: April 13, 2022

No longer available for credit.

Share

Faculty

David Planchard

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France

Egbert F. Smit

Egbert F. Smit, MD, PhD

Professor
Department of Pulmonary Diseases
Leiden University Medical Center
Leiden, Netherlands
Department of Thoracic Oncology
Netherlands Cancer Institute
Amsterdam, Netherlands

Helena Yu

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France

Egbert F. Smit, MD, PhD

Professor
Department of Pulmonary Diseases
Leiden University Medical Center
Leiden, Netherlands
Department of Thoracic Oncology
Netherlands Cancer Institute
Amsterdam, Netherlands

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York